Ramon Bosser

Ramon has more than 28 years of experience in pharma and biotech R&D. He successfully managed to sell the previous company where was the CEO&investor, Origo Biopharma, to Agomab Therapeutics, where he became Head of R&D Operations. Prior to that, he was Managing partner&COO of Spherium Biomed and before that Head of R&D Project Management at Almirall, where he lead the development of aclidinium bromide from phase 1 to phase 3, a project that was later sold to AstraZeneca. Ramon holds a PhD in Cell Biology by the University of Barcelona and did a PADE at IESE business school.